XML 38 R28.htm IDEA: XBRL DOCUMENT
v3.22.2

Revenue - Summary of Revenues Disaggregated by Product Classification and Reportable Segment (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | $ 24,854 | $ 23,873 | $ 73,963 | $ 81,165
Product Sales [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 13,919 | 12,084 | 40,227 | 33,969
Royalties [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 8,795 | 8,796 | 26,738 | 38,182
Research, Development and Other [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 2,140 | 2,993 | 6,998 | 9,014
Operating Segments [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 24,854 | 23,873 | 73,963 | 81,165
Operating Segments [Member] | Medical Device [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 17,528 | 16,755 | 52,889 | 60,858
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 6,741 | 5,493 | 19,970 | 15,464
Operating Segments [Member] | Medical Device [Member] | Royalties [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 7,771 | 7,752 | 23,015 | 23,135
Operating Segments [Member] | Medical Device [Member] | License Fees [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 1,024 | 1,044 | 3,723 | 15,047
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 1,992 | 2,466 | 6,181 | 7,212
Operating Segments [Member] | In Vitro Diagnostics [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 7,326 | 7,118 | 21,074 | 20,307
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | 7,178 | 6,591 | 20,257 | 18,505
Operating Segments [Member] | In Vitro Diagnostics [Member] | Research, Development and Other [Member] |  |  |  |
Disaggregation Of Revenue [Line Items] |  |  |  |
Total revenue | $ 148 | $ 527 | $ 817 | $ 1,802

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_RoyaltyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=srdx_ResearchDevelopmentAndOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=srdx_MedicalDeviceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_LicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=srdx_InVitroDiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |